메뉴 건너뛰기




Volumn 2, Issue 2, 2007, Pages 184-203

Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond

Author keywords

Antimicrobial resistance; Drug reactions and interactions; Pharmacovigilance; Post marketing drug surveillance; Substandard and counterfeit drugs

Indexed keywords

ANTIRETROVIRUS AGENT; ARTEMETHER PLUS BENFLUMETOL; TUBERCULOSTATIC AGENT;

EID: 34248380839     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441690601063299     Document Type: Article
Times cited : (11)

References (64)
  • 1
    • 0037220149 scopus 로고    scopus 로고
    • The Science and Politics of Medicines Control
    • Abraham, J. (2003) The Science and Politics of Medicines Control. Drug Safety, 26, pp. 135-143.
    • (2003) Drug Safety , vol.26 , pp. 135-143
    • Abraham, J.1
  • 2
    • 34248382295 scopus 로고    scopus 로고
    • Supporting Legislation for Independent Post-marketing (Phase IV) Comparative Evaluation of Pharmaceuticals
    • (2003) Supporting Legislation for Independent Post-marketing (Phase IV) Comparative Evaluation of Pharmaceuticals. APHA Policy Statement 2003-1
    • (2003) APHA Policy Statement 2003-1
  • 3
    • 24344465285 scopus 로고    scopus 로고
    • FDA Standards: Good Enough for Government Work?
    • Avorn, J. (2005) FDA Standards: Good Enough for Government Work?. New England Journal of Medicine, 353, pp. 969-972.
    • (2005) New England Journal of Medicine , vol.353 , pp. 969-972
    • Avorn, J.1
  • 6
    • 0030896727 scopus 로고    scopus 로고
    • Reasons for Reporting Adverse Drug Reactions - Some Thoughts Based on an International Review
    • Biriell, D. and Edwards, J.R. (1997) Reasons for Reporting Adverse Drug Reactions-Some Thoughts Based on an International Review. Pharmacoepidemiology Drug Safety, 6, pp. 21-26.
    • (1997) Pharmacoepidemiology Drug Safety , vol.6 , pp. 21-26
    • Biriell, D.1    Edwards, J.R.2
  • 12
    • 34248342830 scopus 로고    scopus 로고
    • (2002)
    • (2002)
  • 13
    • 0035806633 scopus 로고    scopus 로고
    • Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors
    • DeAngelis, C.D., Fontanarosa, P.B. and Flanagin, A. (2001) Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors. Journal of American Medical Association, 286, pp. 89-91.
    • (2001) Journal of American Medical Association , vol.286 , pp. 89-91
    • DeAngelis, C.D.1    Fontanarosa, P.B.2    Flanagin, A.3
  • 15
    • 0028049067 scopus 로고
    • Harmonisation in Pharmacovigilance
    • Edwards, I.R. and Biriell, C. (1994) Harmonisation in Pharmacovigilance. Drug Safety, 10, pp. 93-102.
    • (1994) Drug Safety , vol.10 , pp. 93-102
    • Edwards, I.R.1    Biriell, C.2
  • 16
    • 0029838837 scopus 로고    scopus 로고
    • Can Adverse Drug Reactions be Detected Earlier? A Comparison of Reports by Patients and Professionals
    • Egberts, T.C.G., Smulders, M., De Koning, F.H., Meyboom, R.H. and Leufkens, H.G. (1996) Can Adverse Drug Reactions be Detected Earlier? A Comparison of Reports by Patients and Professionals. British Medical Journal, 313, pp. 530-531.
    • (1996) British Medical Journal , vol.313 , pp. 530-531
    • Egberts, T.C.G.1    Smulders, M.2    De Koning, F.H.3    Meyboom, R.H.4    Leufkens, H.G.5
  • 17
    • 0027248271 scopus 로고
    • Drug Related Hospital Admissions
    • Einarson, T.R. (1993) Drug Related Hospital Admissions. The Annals of Pharmacotherapy, 27, pp. 832-840.
    • (1993) The Annals of Pharmacotherapy , vol.27 , pp. 832-840
    • Einarson, T.R.1
  • 19
    • 33746780482 scopus 로고    scopus 로고
    • Guidance for Industry: E2E Pharmacovigilance Planning
    • US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
    • (2005) Guidance for Industry: E2E Pharmacovigilance Planning. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
    • (2005)
  • 20
    • 25444452228 scopus 로고    scopus 로고
    • Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemilogic Assessment
    • US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
    • (2005) Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemilogic Assessment. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
    • (2005)
  • 21
    • 28644441537 scopus 로고    scopus 로고
    • Reviewer Guidance: Evaluating Risks of Drug Exposure in Human Pregnancies
    • US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
    • (2005) Reviewer Guidance: Evaluating Risks of Drug Exposure in Human Pregnancies. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
    • (2005)
  • 22
    • 34248389520 scopus 로고    scopus 로고
    • Structural Injustice and the MDGs: A Critical Analysis of the Zambian Experience
    • Gaynor, C. (2005) Structural Injustice and the MDGs: A Critical Analysis of the Zambian Experience. Trócaire Development Review, pp. 57-84.
    • (2005) Trócaire Development Review , pp. 57-84
    • Gaynor, C.1
  • 23
    • 34248387082 scopus 로고    scopus 로고
    • (2004) pp. 91-128.
    • (2004) , pp. 91-128
  • 24
    • 34248350170 scopus 로고    scopus 로고
    • (2004)
    • (2004)
  • 25
    • 34248339387 scopus 로고    scopus 로고
    • (2005)
    • (2005)
  • 26
    • 22144469385 scopus 로고    scopus 로고
    • The Flight of Physicians from West Africa: Views of African Physicians and Implications for Policy
    • Hagopian, A., Ofosu, A., Fatusi, A., Biritwum, R., Essel, A. and Hart, L.G. (2005) The Flight of Physicians from West Africa: Views of African Physicians and Implications for Policy. Social Science and Medicine, 61, pp. 1750-1760.
    • (2005) Social Science and Medicine , vol.61 , pp. 1750-1760
    • Hagopian, A.1    Ofosu, A.2    Fatusi, A.3    Biritwum, R.4    Essel, A.5    Hart, L.G.6
  • 27
    • 29144507701 scopus 로고    scopus 로고
    • Viagra's Rise Above Women's Health Issues: An Analysis of the Social and Political Influences on Drug Approvals in the United States and Japan
    • Hollander, I. (2006) Viagra's Rise Above Women's Health Issues: An Analysis of the Social and Political Influences on Drug Approvals in the United States and Japan. Social Science and Medicine, 62, pp. 683-693.
    • (2006) Social Science and Medicine , vol.62 , pp. 683-693
    • Hollander, I.1
  • 28
    • 0035912536 scopus 로고    scopus 로고
    • Lotronex and the FRD: An Erosion of Integrity
    • Horton, R. (2001) Lotronex and the FRD: An Erosion of Integrity. Lancet, 357, pp. 1544-1545.
    • (2001) Lancet , vol.357 , pp. 1544-1545
    • Horton, R.1
  • 33
    • 34248325840 scopus 로고    scopus 로고
    • (2005)
    • (2005)
  • 34
  • 35
    • 21844449462 scopus 로고    scopus 로고
    • The Potential for Interactions Between Antimalarial and Antiretroviral Drugs
    • Khoo, S., Back, D. and Winstanley, P. (2005) The Potential for Interactions Between Antimalarial and Antiretroviral Drugs. AIDS, 19, pp. 995-1005.
    • (2005) AIDS , vol.19 , pp. 995-1005
    • Khoo, S.1    Back, D.2    Winstanley, P.3
  • 37
    • 34248366710 scopus 로고    scopus 로고
    • FDA Rule Changes in Contention Benefits, Dangers of Shorter Drug Review at Center of Debate
    • Krasner, J. (2002) FDA Rule Changes in Contention Benefits, Dangers of Shorter Drug Review at Center of Debate. The Boston Globe
    • (2002) The Boston Globe
    • Krasner, J.1
  • 39
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of Adverse Drug Reactions in Hospitalized Patients, A Meta Analysis of Prospective Studies
    • Lazarou, J., Pomeraz, B.H. and Corey, P.N. (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients, A Meta Analysis of Prospective Studies. Journal of American Medical Association, 279, pp. 1200-1205.
    • (1998) Journal of American Medical Association , vol.279 , pp. 1200-1205
    • Lazarou, J.1    Pomeraz, B.H.2    Corey, P.N.3
  • 40
    • 13444311031 scopus 로고    scopus 로고
    • FDA is Incapable of Protecting US 'Against Another Vioxx'
    • Lenzer, J. (2004) FDA is Incapable of Protecting US 'Against Another Vioxx'. British Medical Journal, 329, p. 1253.
    • (2004) British Medical Journal , vol.329 , pp. 1253
    • Lenzer, J.1
  • 43
    • 34248348486 scopus 로고    scopus 로고
    • (2004)
    • (2004)
  • 46
    • 34248348048 scopus 로고    scopus 로고
    • Ministry of Health
    • (2005) Ministry of Health
    • (2005)
  • 47
    • 0031941382 scopus 로고    scopus 로고
    • Frequency and Cost of Serious Adverse Drug Reactions in a Department of General Medicine
    • Moore, N.D., Lecointre, D., Noblet, C. and Mabille, M. (1998) Frequency and Cost of Serious Adverse Drug Reactions in a Department of General Medicine. British Journal of Clinical Pharmacology, 45, pp. 301-308.
    • (1998) British Journal of Clinical Pharmacology , vol.45 , pp. 301-308
    • Moore, N.D.1    Lecointre, D.2    Noblet, C.3    Mabille, M.4
  • 49
    • 9644260609 scopus 로고    scopus 로고
    • Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
    • Psaty, B.M., Furberg, C.D., Ray, W.A. and Weiss, N.S. (2004) Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis. Journal of American Medical Association, 292, pp. 2622-2631.
    • (2004) Journal of American Medical Association , vol.292 , pp. 2622-2631
    • Psaty, B.M.1    Furberg, C.D.2    Ray, W.A.3    Weiss, N.S.4
  • 52
    • 17444408489 scopus 로고    scopus 로고
    • The WHO 'Roll Back Malaria Project' Planning for Adverse Event Monitoring in Africa
    • Simooya, O. (2005) The WHO 'Roll Back Malaria Project' Planning for Adverse Event Monitoring in Africa. Drug Safety, 28, pp. 277-286.
    • (2005) Drug Safety , vol.28 , pp. 277-286
    • Simooya, O.1
  • 53
    • 34248331505 scopus 로고    scopus 로고
    • (2004)
    • (2004)
  • 54
    • 34248352828 scopus 로고    scopus 로고
    • (2000)
    • (2000)
  • 55
    • 34248398966 scopus 로고    scopus 로고
    • (2002)
    • (2002)
  • 56
    • 34248342829 scopus 로고    scopus 로고
    • (2006)
    • (2006)
  • 57
    • 30444449389 scopus 로고    scopus 로고
    • Reform of Drug Regulation - Beyond an Independent Drug-Safety Board
    • Wayne, A.W. and Stein, C.M. (2006) Reform of Drug Regulation - Beyond an Independent Drug-Safety Board. New England Journal of Medicine, 354, pp. 194-201.
    • (2006) New England Journal of Medicine , vol.354 , pp. 194-201
    • Wayne, A.W.1    Stein, C.M.2
  • 58
    • 1942468862 scopus 로고    scopus 로고
    • Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data
    • Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. and Boddington, E. (2004) Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data. Lancet, 363, pp. 1341-1345.
    • (2004) Lancet , vol.363 , pp. 1341-1345
    • Whittington, C.J.1    Kendall, T.2    Fonagy, P.3    Cottrell, D.4    Cotgrove, A.5    Boddington, E.6
  • 59
    • 0003312086 scopus 로고    scopus 로고
    • How a New Policy Led to Seven Deadly Drugs
    • Willman, D. (2000) How a New Policy Led to Seven Deadly Drugs. Los Angeles Times, p. 1.
    • (2000) Los Angeles Times , pp. 1
    • Willman, D.1
  • 60
    • 0033592242 scopus 로고    scopus 로고
    • Pharmacovigilance Resources in the United Kingdom
    • Wong, I.C.K. (1999) Pharmacovigilance Resources in the United Kingdom. Pharmaceutical Journal, 7059, pp. 285-288.
    • (1999) Pharmaceutical Journal , vol.7059 , pp. 285-288
    • Wong, I.C.K.1
  • 61
    • 34248371826 scopus 로고    scopus 로고
    • (1998)
    • (1998)
  • 62
    • 34248367580 scopus 로고    scopus 로고
    • (2002)
    • (2002)
  • 63
    • 34248373077 scopus 로고    scopus 로고
    • (2004)
    • (2004)
  • 64
    • 34248366286 scopus 로고    scopus 로고
    • (2004)
    • (2004)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.